Related Experiment Videos
The effect of methylprednisolone on hypoxic pulmonary vasoconstriction in the newborn late-gestation lamb
1Cardiovascular Research Institute, University of California, San Francisco 94143.
Abstract:
Methylprednisolone (30 mg/kg), which inhibits a number of mediators of hypoxic pulmonary vasoconstriction derived from arachidonic acid, has been found to alleviate hypoxic pulmonary vasoconstriction in adult humans and in the isolated rat lung preparation. We studied the effect of 30 mg/kg of methylprednisolone on the pulmonary vascular response to hypoxia in six late-gestation newborn lambs. During hypoxia, pulmonary vascular resistance nearly doubled compared with the baseline hyperoxic state. This was true both before and after administration of methylprednisolone. We conclude that methylprednisolone, when administered at the dosage used in previous studies of adult humans and animals, does not affect the response of the pulmonary vascular bed to hypoxia in newborn lambs.
Insights
Methylprednisolone did not alleviate hypoxic pulmonary vasoconstriction in newborn lambs, despite its known effects in adults. This study investigated its impact on pulmonary vascular resistance during hypoxia in lambs.
Area of Science:
- Neonatal Physiology
- Pulmonary Medicine
- Pharmacology
Background:
- Hypoxic pulmonary vasoconstriction (HPV) is a critical circulatory response.
- Methylprednisolone inhibits mediators of HPV in adults and animal models.
- The effect of methylprednisolone on HPV in neonates is not well-established.
Purpose of the Study:
- To determine if methylprednisolone affects the pulmonary vascular response to hypoxia in late-gestation newborn lambs.
Main Methods:
- Six newborn lambs in late gestation were studied.
- Pulmonary vascular resistance was measured during normoxia (hyperoxia) and hypoxia.
- Methylprednisolone (30 mg/kg) was administered, and the response to hypoxia was re-evaluated.
Main Results:
- Hypoxia significantly increased pulmonary vascular resistance in lambs, nearly doubling it compared to the hyperoxic baseline.
- This increase in pulmonary vascular resistance during hypoxia was observed both before and after methylprednisolone administration.
- Methylprednisolone did not alter the pulmonary vascular response to hypoxia in the studied lambs.
Conclusions:
- Methylprednisolone, at a dosage effective in adult humans and animals, does not attenuate hypoxic pulmonary vasoconstriction in newborn lambs.
- The pulmonary vascular bed of newborn lambs responds to hypoxia independently of methylprednisolone at the tested dosage.
- Further research may be needed to explore alternative or adjunctive therapies for neonatal hypoxic pulmonary hypertension.